[
    [
        {
            "time": "",
            "original_text": "A股五朵金花：贵州茅台 恒瑞医药 迈瑞医疗 爱尔眼科 中公教育",
            "features": {
                "keywords": [
                    "贵州茅台",
                    "恒瑞医药",
                    "迈瑞医疗",
                    "爱尔眼科",
                    "中公教育"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "医药",
                    "教育"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股五朵金花：贵州茅台 恒瑞医药 迈瑞医疗 爱尔眼科 中公教育",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]